Dosing of the first patient in the third cohort, along with...

First 62 Last

Share
Profile

Follow
aidoaido

1,366 Posts.

43

02/09/15

13:36

Post #: 15920364
Share
Originally posted by Blane66 ↑

I think you'll find the original dosing comments, ahem, enlightening:

The primary end-point for the clinical trial will be to assess safety and tolerance of TT-034 in HCV-infected patients. Benitec expects to report a preliminary assessment of safety data to the ASX throughout the clinical trial on the following basis:

Notification that the second patient in the trial has been dosed;

Dosing of the first patient in the second cohort, along with comments on the first cohort;

Dosing of the first patient in the third cohort, along with comments on the second cohort;

Dosing of the first patient in the fourth cohort, along with comments on the third cohort; and

Dosing of the first patient in the fifth cohort, along with comments on the fourth cohort.

Notwithstanding this anticipated schedule, the Company will provide an update to the ASX at any time should a material event occur that relates to the clinical trial.

http://www.irasia.com/listco/au/benitec/press/p140711.htm

Expand

Dosing of the first patient in the third cohort, along with comments on the second cohort;

Am I missing something then , dosing #6 was announced on the 25/6/15, but no comment yet on #4 or #5 biopsies (SH expressions)? I believe they are killing the shareholder value by with holding this data.
It looks more like a one trick pony every day, and the pony is kept in the stables.
BLT Price at posting: 52.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Bitcoin: Current State of Play & Where to Next | Swyftx

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Emerald & Azure score Digger & Dealer awards

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

There are more pages in this discussion • 4 more messages in this thread...

First 62 Last

Add BLT (ASX) to my watchlist

Dosing of the first patient in the third cohort, along with...

Top Stories

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

True North increases silver metal at QLD's Vero deposit by 20%

Bitcoin: Current State of Play & Where to Next | Swyftx

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Emerald & Azure score Digger & Dealer awards

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Featured News